Vielight Neuro RX Gamma device and irradiation configuration used in the randomized, double-blind, sham-controlled trial. The ...
MedPage Today on MSN
GLP-1 Drugs Tied to Mortality Reduction in Colon Cancer Patients With Obesity
SAN FRANCISCO -- Patients with colon cancer and comorbid obesity treated with GLP-1 receptor agonists had lower mortality and ...
FDA removes black box warnings for most MHT products, reflecting evidence that breast cancer risk varies by formulation, ...
ImmunityBio stock jumps after strong trial updates in bladder cancer and lymphoma, with enrollment ahead of schedule and FDA ...
News-Medical.Net on MSN
Digital coaching boosts asthma control and quality of life
While online coaching improves asthma management short-term, it does not sustain physical activity changes, highlighting the ...
Research has shown that people who stop taking GLP-1 drugs, such as Ozempic and Wegovy, typically experience weight regain ...
Background While female sex has historically been associated with worse outcomes following surgical aortic valve replacement, ...
ImmunityBio, Inc. (NASDAQ: IBRX) today announced an update on the status of enrollment in its randomized registrational trial ...
Mazdutide, a dual glucagon and GLP-1 agonist, delivers greater HbA1c and weight reductions than dulaglutide in people with ...
A new study published in the journal of Medicine showed that the immediate implant placement (IIP) protocol demonstrated a ...
Exercise is as effective as psychological therapy and taking antidepressants for alleviating symptoms of depression. | ...
Diabetic participants showed a 47.3% rate of coronary artery calcification (CAC) progression, compared to 28.4% in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results